Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 10;8(11):e0546.
doi: 10.1097/HC9.0000000000000546. eCollection 2024 Nov 1.

Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort

Cristian Sanchez-Torres  1 , Ana Ramirez Tovar  1 , Kelsey Chatman  1 , Heather L Morris  2 , Feng Yu  2 , Andrea R Mospan  2 , Anna Mae Diehl  3 , Daniel H Leung  4 , Preeti Viswanathan  5 , James E Squires  6 , Sirish Palle  7 , Miriam B Vos  1
Affiliations

Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort

Cristian Sanchez-Torres et al. Hepatol Commun. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Heather L. Morris, Feng Yu, Andrea R. Mospan: employees of Target RWE. Miriam B. Vos: consultant to Target RWE, Eli Lilly, Boehringer Ingelheim, Madrigal, and Inventiva. Advisor to Albireo. Grants from Target RWS, Labcorp and Sonic Incytes. Stock in Thiogenesis and Tern. Anna Mae Diehl: Grants from Boehringer Ingelheim, Tune Therapeutics, Hepta-Bio, Intercept, Hanmi, Viking, and GlaxoSmithKline. Daniel H. Leung: Advisor to AstraZeneca and Vertex. Grants from Gilead and Cystic Fibrosis Foundation. James E. Squires: advisor to Sanofi. The remaining authors have no conflicts to report.

References

    1. European Association for the Study of the Liver Terrault Norah A., American Association for the Study of Liver Diseases Castro-Narro Graciela, Latin American Association for the Study of the Liver Krag Aleksander, & Asian Pacific Association for the Study of the Liver . Ending stigmatizing language in alcohol and liver disease: A liver societies’ statement. Hepatology. 2023;78:1682–1683. - PubMed
    1. Barritt AS, 4th, Yu F, Mospan AR, Newsome PN, Roden M, Morris HL, et al. . High concordance between nonalcoholic fatty liver disease and metabolic dysfunction associated steatotic liver disease in the TARGET-NASH real world cohort. Am J Gastroenterol. 2024;119:1624–1627. - PubMed
    1. Barritt AS, IV, Gitlin N, Klein S, Lok AS, Loomba R, Malahias L, et al. . Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemp Clin Trials. 2017;61:33–38. - PubMed
    1. Kim HP, Idowu MO, Mospan AR, Allmon AG, Roden M, Newsome P, et al. . Liver biopsy in the real world—Reporting, expert concordance and correlation with a pragmatic clinical diagnosis. Aliment Pharmacol Ther. 2021;54:1472–1480. - PubMed
    1. Hagström H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80:e76–e77. - PubMed